Fox Business - The Power to Prosper
Search Site

Swine Flu

Dow nears 2-year high

Scott Martin of United Advisors, Jack Hough of Barron’s and WSJ’s James Freeman discuss today’s markets and new Ebola vaccines..

Read More

  1. The beginning of a correction?

    Reason Magazine editor-in-chief Matt Welch, Stifel Nicolaus portfolio manager Chad Morganlander and First Trust Advisors chief economist Brian Wesbury discuss the markets.

  2. Illegal immigration causing a public health crisis?

    Dr. Elizabeth Vliet on health risks associated with illegal immigration.

  3. Faulty flu drugs?

    FOX News Medical A-Team’s Dr. Manny Alvarez weighs in on a new study that says some claims by Tamiflu may be untrue.

  4. High hog prices smoke the pork industry

    FBN’s Jeff Flock on the rise in hog prices due to the Swine Flu .

  5. U.S. Gives Glaxo Up To $200 Million for Antibiotic Research

    Concerned about the need to fight antibiotic resistance and possible bioterrorist attacks, the U.S. government will give drug maker GlaxoSmithKline PLC (GSK, GSK.LN)...

  6. Roche Agrees to Release Tamiflu Trial Data

    Bowing to years of pressure, Swiss drug maker Roche Holding AG (RO.EB) said Friday it would release clinical trial data for its blockbuster Tamiflu influenza treatme...

  7. Roche Agrees To Release All Tamiflu Trial Data

    Swiss drug maker Roche Holding AG (ROG.VX) said Friday it has agreed to give outside researchers access to all its clinical trial data for Tamiflu, a blockbuster inf...

  8. Roche to Expand Access to Clinical Trial Data

    Roche Holding AG (ROG.VX) said Tuesday it would provide greater access to the results of its clinical trials, bowing to pressure from outside researchers seeking to ...

  9. Could the Flu Trigger a Recession?

    A high body count is not the only meaningful number attached to a pandemic. The potential cost of a global outbreak of the flu or some other highly contagious diseas...

  10. Flu Virus Hits Early Across U.S.

    Dr. Marc Siegel on efforts to fight the flu virus this year.

  11. Flu Season’s Here, Are You Getting a Shot?

    Dr. Marc Siegel on the benefits of getting a flu shot this year.

  12. Analysis: Washington, Wall Street misreading each other again as cliff nears

    Exit presidential elections. Enter looming budget crisis. And once again, a disconnect between how Washington and Wall Street see the world could cause pain for inve...

  1. Ebola threat boosts sales for infection protection kits

    LifeSecure Emergency Solutions Founder David Scott on the company and how the Ebola virus is helping their business.

  2. Ron Colburn: We don’t have a response for Ebola yet

    Former U.S. Border Patrol National Deputy Chief Ron Colburn on concerns about the government’s handling of the Ebola crisis.

  3. Shares of Ebola drug maker getting crushed

    Empyrion Wealth Management President Kimberly Foss, NewOak Capital President James Frischling, FBN’s Charles Payne, retail analyst Hitha Prabhakar and Penn Financial Group founder Matt McCall on the impact of the Ebola crisis on pharmaceutical stocks.

  4. Is technology changing lives for the better?

    FBN’s Charles Payne, Lebenthal Asset Management’s James Lebenthal, Tea Party News Network News Director Scottie Nell Hughes, Cash Smartwatch founder Nicole Lapin, retail analyst Hitha Prabhakar and Penn Financial Group founder Matt McCall on the impact of technology on society and productivity.

  5. Are the markets paying attention to Ebola?

    Layfield Report CEO John Layfield on Ebola’s impact on the U.S. markets, the September jobs report and the state of the U.S. economy.

  6. Can the Ebola outbreak be controlled?

    Professor of Preventative Medicine Dr. William Schaffner on the steps to controlling the Ebola outbreak.

  7. What would it take to make America great again?

    Takimag contributor Gavin McInnes and former Rep. Thad McCotter on a new poll showing faith in American Exceptionalism fading fast.

‹ Prev12345Next ›
Freebase CC-BY
Source: Swine Flu on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL